Prognostic imaging of neuroblastoma Anna-Liisa Brownell Editorial Commentary 26 March 2014 Pages: 1043 - 1045
Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma Arnoldo PiccardoMatteo PuntoniAlberto Garaventa Original Article 22 February 2014 Pages: 1046 - 1056
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2) Pierre VeraSandrine Mezzani-SaillardBernard Dubray Original Article 22 February 2014 Pages: 1057 - 1065
PET/MRI and PET/CT in follow-up of head and neck cancer patients Marcelo A. QueirozMartin HüllnerPatrick Veit-Haibach Original Article 28 February 2014 Pages: 1066 - 1075
Prognostic relevance of 18F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan Dimosthenis AndreouHenrike BoldtPer-Ulf Tunn Original Article 12 February 2014 Pages: 1076 - 1083
Diagnostic accuracy of 18F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma Punit SharmaSachin JainRakesh Kumar Original Article 17 January 2014 Pages: 1084 - 1092
Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection Hua-Xiang XuTao ChenXian-Jun Yu Original Article 13 February 2014 Pages: 1093 - 1102
Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? Dimitri BellevreCécile Blanc FournierNicolas Aide Original Article Open access 22 February 2014 Pages: 1103 - 1112
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients Michel MeignanMyriam SasanelliAnnibale Versari Original Article 26 February 2014 Pages: 1113 - 1122
Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin’s lymphoma Agostino ChiaravallotiRoberta DanieliOrazio Schillaci Original Article 22 February 2014 Pages: 1123 - 1132
Characterizing bone marrow involvement in Hodgkin’s lymphoma by FDG-PET/CT Michal Weiler-SagieOlga KagnaOra Israel Original Article 26 February 2014 Pages: 1133 - 1140
Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy Sofie Van BinnebeekKristof BaeteChristophe M. Deroose Original Article 26 March 2014 Pages: 1141 - 1157
Twins in spirit part II: DOTATATE and high-affinity DOTATATE—the clinical experience Claudia BrogsitterKlaus ZöphelJörg Kotzerke Original Article 15 February 2014 Pages: 1158 - 1165
Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues Beatrice WaserJean Claude Reubi Original Article 12 February 2014 Pages: 1166 - 1171
PET/MR attenuation correction: where have we come from and where are we going? Dimitris VisvikisFlorian MonnierHadi Fayad Editorial Commentary 15 March 2014 Pages: 1172 - 1175
A comparison of CT- and MR-based attenuation correction in neurological PET John C. DicksonCelia O’MearaAnna Barnes Original Article 15 January 2014 Pages: 1176 - 1189
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer’s disease Sofie M. AdriaanseKoene R. A. van DijkBart N. M. van Berckel Original Article 11 March 2014 Pages: 1190 - 1198
18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors Mirwais WardakChristiaan SchiepersSung-Cheng Huang Original Article 07 March 2014 Pages: 1199 - 1209
Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease Andreas MatuschCarsten SaftAndreas Bauer Original Article 25 February 2014 Pages: 1210 - 1220
Biventricular pacing in heart failure: right is not wrong! Prem Soman Editorial Commentary 03 April 2014 Pages: 1221 - 1223
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging Guang-Uei HungJin-Long HuangJi Chen Original Article 28 February 2014 Pages: 1224 - 1231
Sites of latest mechanical activation as assessed by SPECT myocardial perfusion imaging in ischemic and dilated cardiomyopathy patients with LBBB Xianhe LinHuiqin XuJi Chen Original Article 28 February 2014 Pages: 1232 - 1239
Attenuated right ventricular energetics evaluated using 11C-acetate PET in patients with pulmonary hypertension Keiichiro YoshinagaHiroshi OhiraNagara Tamaki Original Article 11 March 2014 Pages: 1240 - 1250
Authorship problems in scientific literature and in nuclear medicine: the point of view of the young researcher Salvatore AnnunziataAlessandro Giordano Editorial 26 March 2014 Pages: 1251 - 1254
Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy S. DizdarevicR. McCreadyI. Ziv Letter to the Editor 25 February 2014 Pages: 1255 - 1256
Comment on: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer Carlo AprileFederica E. BuroniMarco G. Persico Letter to the Editor 26 March 2014 Pages: 1257 - 1258
Response to comment by Aprile et al.: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer F. GiammarileN. AlazrakiS. Vidal Sicart Letter to the Editor 26 March 2014 Pages: 1259 - 1260
Paul S. Sidhu, Suzanne M. Ryan, Phillip F.C. Lung (Eds): FRCR 2B Viva: A Case-based Approach Valentina PiscopoLuigi Mansi Book Review 22 January 2014 Pages: 1261 - 1262
Ignasi Carrio and Pablo Ros (Eds.): PET/MRI Methodology and Clinical Applications Luigi Mansi Book Review 02 April 2014 Pages: 1263 - 1263
FDG PET/CT in autoimmune pancreatitis Cristina NanniRossella RomagnoliStefano Fanti Image of the Month 22 February 2014 Pages: 1264 - 1265
